• FREE

    Major Depressive Disorder (MDD): Updates from the American Psychiatric Association Annual Meeting (APA) 2017

    Major Depressive Disorder (MDD): Updates from the American Psychiatric Association Annual Meeting (APA) 2017 includes major findings about major depressive disorder from APA 2017, including clinical trial data relevant to both community and health-system practice and recognized barriers to implementing those findings in practice.

    After reviewing Major Depressive Disorder (MDD), you will be able to:
    • Recall the most impactful findings about Major Depressive Disorder (MDD) from the APA 2017 Annual meeting relating to MDD pathophysiology, progression, & prognosis.
    • Describe the most impactful findings about MDD from the APA 2017 Annual meeting relating to using the similarities & differences between MDD & bereavement to inform good clinical care.
    • Summarize the most impactful findings about MDD from the APA 2017 Annual meeting relating to old, new, emerging, and potential new targets for treating of MDD and apply them to patient cases.

    Target Audience:
    Healthcare professionals specializing in family medicine, internal medicine, mental health, neurology and psychiatry, or those who otherwise commonly care for patients with MDD or related psychiatric diseases.

    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: July 18, 2017
    • Expiration of CME credit: July 18, 2019
  • FREE

    Osteoporosis Management: Advances in Pharmacotherapy

    After viewing Osteoporosis Management: Advances in Pharmacotherapy, you will be able to:
    • Apply the results of diagnostic imaging and pertinent past medical history to determine a given patient’s diagnosis of osteoporosis or osteopenia
    • Describe the criteria for initiation of pharmacotherapy for osteoporosis treatment and prevention
    • Identify investigational pharmacotherapeutic treatments for management of osteoporosis, and describe their mechanisms of action and likely place in therapy
    • Describe the challenges associated with treating patients with osteoporosis, focus specifically on the risks (e.g., adverse drug reactions, drug interactions, etc.) of the agents used to treat and prevent osteoporosis and apply the information in optimizing patient care

    Target Audience:
    Endocrinologists, geriatricians, internists; physician assistants, nurse practitioners, nurses, and pharmacists who specialize in those areas of medicine and those who otherwise commonly care for patients with osteoporosis.

    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: July 4, 2017
    • Expiration of CME credit: July 4, 2019
  • FREE

    Updates in Alzheimer Disease (AD) and Its Complications: Pharmacotherapy and Barriers to Optimal Care

    This free online CME course provides key insights around Alzheimer’s Disease (AD) and will lead to better understanding and treatment of the condition.

    Topics covered in this course include:

    • AD Treatment
    • AD Patient Cases
    • AD Clinical Pearls
    • ADPathophysiological process
    • Epidemiology

    After completing this course, you will better be able to:

    • Describe validated diagnostic and screening method(s) for AD and apply them to a patient case
    • Discuss the neuropathophysiology of AD and how it relates to presently available AD treatments’ mechanisms
    • List present and emerging pharmacotherapeutic therapies for the treatment of AD and its complications and apply them to patient cases, taking into account comorbid disease states and drug therapies
    • Describe the impact of medication adherence on patient outcomes and formulate strategies to improve adherence in patients with AD

    Target audience: Healthcare professionals specializing in: neurology, gerontology, internal medicine, palliative care, or those who otherwise commonly care for patients with AD or who frequently encounter them or their caregivers in practice.

    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: July 07, 2018
    • Expiration of CME credit: July 07, 2020
  • FREE

    Hypoparathyroidism: therapeutic updates and optimizing treatment

    This free online CME course provides insights into Hypoparathyroidism and how to most effectively treat the condition.

    Topics covered in the course include:

    • Treatment of hypoparathyroidism
    • Barriers to optimal care
    • Hypoparathyroidism patient cases

    After completing thise course, you will better be able to:

    • Describe the pathophysiology and underlying etiologies of hypoparathyroidism and apply these to patient cases.
    • Describe the clinical manifestations of hypoparathyroidism and discuss how they may have relevance to treatment targets.
    • Identify available therapeutic options for hypoparathyroidism and incorporate these in the development of treatment plans in patient cases.
    • Define patient-specific goals related to the management of hypoparathyroidism.

    Target Audience: Endocrinologists and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in endocrinology and internal medicine; and any other healthcare professionals with an interest in or who clinically encounter patients with hypoparathyroidism.

    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: June 06, 2018
    • Expiration of CME credit: June 06, 2020
  • FREE

    Male Osteoporosis Management: Advances in Pharmacotherapy

    This free online CME program gives an in-depth look into male Osteoporosis and will help physicians treat this condition better among male patients.

    Topics covered in this course include:

    • Osteoperosis Epidemiology
    • Osteoperosis Risk factors
    • Guidance on screening criteria in men
    • Osteoperosis Treatment options

    After completing this program, you will better be able to:

    • Apply screening criteria for male osteoporosis to a given patient
    • Describe the criteria for initiation of pharmacotherapy for osteoporosis treatment and prevention and apply them to a patient case
    • Identify present pharmacotherapeutic treatments for management of male osteoporosis, and describe their mechanisms of action and place in therapy
    • Describe investigational pharmacotherapeutic treatments for management of male osteoporosis, and describe their mechanisms of action and likely place in therapy
    • Describe the challenges associated with treating patients with male osteoporosis, focus specifically on the risks (e.g., adverse drug reactions, drug interactions, et cetera) of the agents used to treat and prevent osteoporosis and apply the information in optimizing patient care in a patient case

    Target Audience: Primary care physicians and endocrinologists; physician assistants, nurse practitioners, nurses, and pharmacists who practice in endocrinology and internal medicine; and any other healthcare professionals with an interest in or who clinically encounter patients with male osteoporosis.

    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: April 30, 2018
    • Expiration of CME credit: April 30, 2020